scholarly journals Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer

2022 ◽  
Vol Volume 14 ◽  
pp. 169-176
Author(s):  
Yingjie Lu ◽  
Xuelin Zhang ◽  
Huibiao Zhang ◽  
Zhenghong Zhu
PLoS ONE ◽  
2011 ◽  
Vol 6 (8) ◽  
pp. e22961 ◽  
Author(s):  
Yen-Tsung Huang ◽  
Xihong Lin ◽  
Lucian R. Chirieac ◽  
Ray McGovern ◽  
John C. Wain ◽  
...  

2019 ◽  
Vol Volume 12 ◽  
pp. 3817-3827
Author(s):  
Chang Liu ◽  
Hui Yu ◽  
Xuxia Shen ◽  
Jie Qiao ◽  
Xianghua Wu ◽  
...  

2020 ◽  
Vol 17 (4) ◽  
pp. 271-282
Author(s):  
Jianwei Liang ◽  
Teng Sun ◽  
Guoxiang Wang ◽  
Hao Zhang

Aim: We aimed to investigate the clinical significance and biological function of miR-203a-3p in non-small-cell lung cancer (NSCLC). Methods: The association between miR-203a-3p expression and clinicopathological parameters in NSCLC was assessed by χ2 test. Kaplan–Meier method and Cox regression model were applied to evaluate the prognosis value of miR-203a-3p. The biological function of miR-203-3p was explored using CCK-8 and transwell assays. Results: Significantly downregulated miR-203a-3p was associated with TNM stage, lymph node metastasis and poor prognosis. AVL9 was identified as a direct target of miR-203a-3p. Functionally, we found overexpression of miR-203a-3p inhibited cell proliferation, migration and invasion in NSCLC cells by targeting AVL9. Conclusion: Collectively, targeting the miR-203a-3p/ AVL9 axis might help to develop useful therapeutic target for NSCLC.


2020 ◽  
Author(s):  
Bin Liu ◽  
Jing Li ◽  
JiMan Li ◽  
GuangYuan Liu ◽  
YongSheng Wang

Abstract As a serious malignancy with high incidence and fatality, non-small cell lung cancer (NSCLC) has affected millions of people each year worldwide. However, the 5-year survival rate of NSCLC is still not satisfactory. Therefore, it is particularly imperative and necessary to explore the underlying molecular mechanisms of NSCLC to contribute to the potential therapeutic targets and strategies. Six clinical samples including three normal tissues and three cancer tissues obtained from patients diagnosed with NSCLC were sequenced through Illumina Hiseq2500 sequencer. Differentially expressed lncRNAs and mRNAs analysis were implemented using the edgeR, and the function of differentially expressed lncRNAs and mRNAs were analyzed with GO and KEGG enrichment analysis. Then, top 10 dysregulated lncRNAs and mRNAs were screened out. Finally, the co-expression, biological function and pathway networks of dysregulated lncRNA with the predicted target genes were constructed. Differentially expressed lncRNAs and mRNAs could distinguish cancerous tissues from normal tissues. The functions and KEGG pathway of differentially expressed lncRNAs and mRNAs mainly were enriched in immune response, metabolism, phagosome, cytokine receptor interaction and IL-17 signaling pathway. The co-expression network revealed that top ten dysregulated lncRNAs were interacted with IGH gene cluster. Furthermore, the biological function and pathway network also indicated that dysregulated lncRNAs were involved in immune process. The results demonstrated that the biologic function of dysregulated lncRNAs that may be involved in immune process. Our data provides a foundation of the biologic significances of lncRNAs to contribute to the therapeutic targets and strategies for NSCLC to promote the survival for patients.


2021 ◽  
Author(s):  
Lina Zhu ◽  
Ke Zhang ◽  
Chu Zhang ◽  
Hui Yu ◽  
Lirong Zhu

Aim: miRNAs have been found to be involved in the tumor progression. This study aimed to assess the prognostic significance and biological function of miRNA-1231 (miR-1231) in non-small-cell lung cancer (NSCLC). Materials & methods: Expression of miR-1231 was measured by using quantitative real-time PCR. The prognosis value of miR-1231 was evaluated by Kaplan–Meier survival curves and Cox regression analysis. The biological function of miR-1231 was further studied. Results: Expression of miR-1231 in NSCLC patients and NSCLC cell lines were decreased. MiR-1231 was an independent prognostic biomarker. Overexpression of miR-1231 inhibited NSCLC cell proliferation, migration and invasion. Conclusion: Downregulated expression of miR-1231 serves as a prognostic biomarker of NSCLC and may be a potential therapeutic target.


Sign in / Sign up

Export Citation Format

Share Document